Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BZUN NYSE:LHC NYSE:LITB NASDAQ:RNLX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBZUNBaozun$2.95-4.1%$2.86$2.11▼$4.38$170.65M0.31467,605 shs542,280 shsLHCLeo Holdings Corp. II$11.87$11.47$9.98▼$11.89$165.60M-0.0117,580 shsN/ALITBLightInTheBox$1.34+2.7%$1.24$0.91▼$4.80$24.55M0.2125,247 shs7,986 shsRNLXRenalytix$0.21$0.23$0.18▼$2.40$17.18M2.721.45 million shs934,496 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBZUNBaozun-0.65%+18.53%+19.46%+34.65%+25.31%LHCLeo Holdings Corp. II0.00%0.00%0.00%0.00%0.00%LITBLightInTheBox-0.08%-5.75%+13.44%-34.96%-70.72%RNLXRenalytix0.00%0.00%0.00%0.00%-29.24%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBZUNBaozun1.3769 of 5 stars1.35.00.00.01.42.50.6LHCLeo Holdings Corp. IIN/AN/AN/AN/AN/AN/AN/AN/ALITBLightInTheBoxN/AN/AN/AN/AN/AN/AN/AN/ARNLXRenalytixN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBZUNBaozun 2.50Moderate Buy$3.208.66% UpsideLHCLeo Holdings Corp. II 0.00N/AN/AN/ALITBLightInTheBox 0.00N/AN/AN/ARNLXRenalytix 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBZUNBaozun$1.29B0.13$0.14 per share20.46$10.40 per share0.28LHCLeo Holdings Corp. IIN/AN/A$1.40 per share8.46($1.49) per shareN/ALITBLightInTheBox$255.29M0.10N/AN/A($0.72) per share-1.85RNLXRenalytix$2.29M7.50N/AN/A($0.10) per share-2.07Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBZUNBaozun-$18.68M-$0.43N/A∞N/A-1.93%-4.46%-1.84%8/27/2025 (Estimated)LHCLeo Holdings Corp. II$13.16MN/A0.00∞N/AN/A-38.86%2.68%N/ALITBLightInTheBox-$2.49M$0.1013.35∞N/A0.63%-11.29%2.04%N/ARNLXRenalytix-$33.46M-$0.39N/A∞N/A-1,461.60%N/A-281.40%N/ALatest LITB, BZUN, LHC, and RNLX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2025Q1 2025LITBLightInTheBoxN/A$0.01N/A$0.01N/A$47.02 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBZUNBaozunN/AN/AN/AN/AN/ALHCLeo Holdings Corp. IIN/AN/AN/AN/AN/ALITBLightInTheBoxN/AN/AN/AN/AN/ARNLXRenalytixN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBZUNBaozunN/A1.991.65LHCLeo Holdings Corp. IIN/A0.020.02LITBLightInTheBoxN/A0.330.27RNLXRenalytixN/A0.530.53Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBZUNBaozun47.29%LHCLeo Holdings Corp. II36.51%LITBLightInTheBox56.77%RNLXRenalytix9.92%Insider OwnershipCompanyInsider OwnershipBZUNBaozun59.20%LHCLeo Holdings Corp. II1.30%LITBLightInTheBox62.20%RNLXRenalytix18.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBZUNBaozun7,65057.75 million23.56 millionOptionableLHCLeo Holdings Corp. II313.95 million13.77 millionNot OptionableLITBLightInTheBox97018.39 million6.95 millionNot OptionableRNLXRenalytix10082.96 million63.06 millionOptionableLITB, BZUN, LHC, and RNLX HeadlinesRecent News About These CompaniesRenalytix shares gain as billable test numbers set new company recordApril 10, 2025 | proactiveinvestors.co.ukRenalytix Adjusts Share Capital Amid Fundraising ShortfallNovember 6, 2024 | markets.businessinsider.comRenalytix PLC (RNLX) Stock: Unveiling Its Hidden StrengthsOctober 2, 2024 | bovnews.comBRenalytix PLC (RNLX) Stock: Surpassing Expectations in the Market?September 11, 2024 | bovnews.comBWhat Factors Have Led to Renalytix PLC (RNLX) Stock Trading -90.00% Below Its 52-Week High?September 2, 2024 | bovnews.comBThe Renalytix Plc ADR (RNLX) Stock expansion path aheadJuly 23, 2024 | bovnews.comBRenalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond USJuly 11, 2024 | globenewswire.comRenalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting DeterminationJune 27, 2024 | globenewswire.comMedicare Issues Final Coverage Determination for kidneyintelX.dkdJune 14, 2024 | globenewswire.comWhat do you think? Take A Moment To Read: Renalytix Plc ADR (RNLX) StockMay 27, 2024 | bovnews.comBIs Renalytix Plc ADR (RNLX) Stock Paving the Way for Earnings?May 16, 2024 | bovnews.comBRNLX Stock Earnings: Renalytix Misses EPS, Misses Revenue for Q3 2024May 15, 2024 | investorplace.comRenalytix AI GAAP EPS of -$0.08 beats by $0.01, revenue of $0.54M misses by $0.56MMay 15, 2024 | msn.comRenalytix Reports Financial Results for Third Quarter of Fiscal Year 2024May 15, 2024 | globenewswire.comRenalytix AI is about to announce its earnings — here's what Wall Street expectsMay 15, 2024 | markets.businessinsider.comRenalytix AI earnings: here's what Wall Street expectsMay 14, 2024 | markets.businessinsider.comRenalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15May 9, 2024 | finance.yahoo.comRenalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15May 9, 2024 | globenewswire.comRenalytix Plc (RNLX) Stock Price, News, Quote & History - Yahoo FinanceApril 28, 2024 | finance.yahoo.comRenalytix files to sell 19.99M ordinary shares for holdersApril 17, 2024 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeLITB, BZUN, LHC, and RNLX Company DescriptionsBaozun NASDAQ:BZUN$2.94 -0.13 (-4.07%) As of 02:34 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Baozun Inc., through its subsidiaries, provides end-to-end e-commerce solutions to brand partners in the People's Republic of China. The company operates through two segments, E-Commerce and Brand Management (BBM). The E-Commerce segment offers brands' store operations, customer services and value-added services in logistics and supply chain management, IT, and digital marketing. The Brand Management segment provides brand management, strategic and tactic positioning, branding and marketing, retail and e-commerce operations, supply chain, and logistics and technology services. It serves brand partners in various categories, including apparel and accessories, appliances, electronics, home and furnishings, food and health products, beauty and cosmetics, fast moving consumer goods, mother and baby products, and automobiles. The company was formerly known as Baozun Cayman Inc. and changed its name to Baozun Inc. in March 2015. Baozun Inc. was founded in 2007 and is headquartered in Shanghai, the People's Republic of China.Leo Holdings Corp. II NYSE:LHCLeo Holdings Corp. II does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Nassau, the Bahamas.LightInTheBox NYSE:LITB$1.34 +0.04 (+2.69%) As of 02:28 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.LightInTheBox Holding Co., Ltd., together with its subsidiaries, operates as an online retailer that delivers products directly to its consumers worldwide. The company provides apparel products; and other general merchandise products, such as small accessories and gadgets, home garden, toys and hobbies, electronics and communication devices, and other products. It also offers supplier chain management, research and development, customer, marketing, warehouse management, local delivery, and fulfillment services, as well as engages in the product sourcing, marketing, and operation of its websites and mobile applications. The company provides its products through www.lightinthebox.com and www.ezbuy.sg, and other websites and mobile applications. LightInTheBox Holding Co., Ltd. was founded in 2007 and is based in Singapore.Renalytix NASDAQ:RNLXRenalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score. Its products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. Renalytix Plc has a license agreement with Mount Sinai Health System to develop and commercialize licensed products in connection with the application of artificial intelligence for the diagnosis of kidney disease; and Joslin Diabetes Center, Inc. for developing and commercializing products for diagnosing and predicting kidney disease using biomarkers. The company also has a partnership agreement with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to implement an advanced clinical care model designed to improve kidney health and reduce kidney disease progression and kidney failure. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. Renalytix Plc was incorporated in 2018 and is based in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Rigetti Soars 30% on Latest Quantum Leap: What It Means Long-Term Domino’s Delivers Another Discounted Entry for Income Investors Palantir Bulls and Bears Set for an August Showdown 3 Reasons Palo Alto Networks Is Becoming a Wall Street Favorite Vertical Aerospace Stock Trades at Discount After VX4 Milestone GameStop: Clarity Brings Renewed Confusion for Meme Stock Analysts Are Backing Qualcomm: Is a Breakout Coming? TSLA Earnings Week: Can Tesla Break Through $350? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
